Dose-dependent hepatic response to subchronic administration of nandrolone decanoate

Medicine and Science in Sports and Exercise

Volumn 40, Issue 5, 2008, Pages 842-847

  Vieira, Rodolfo Paula ^a,c   França, Rafaela Ferreira ^b   Damaceno Rodrigues, Nilsa Regina ^a   Dolhnikoff, Marisa ^a   Caldini, ÉLia Garcia ^a   Carvalho, Celso Ricardo Fernandes ^a   Ribeiro, Welington ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DE PESQUISA E DESENVOLVIMENTO   (Brazil)

^c Andorinhas 271   (Brazil)

Author keywords

Androgenic anabolic steroids; Collagen; Hepatotoxicity; Kupffer cells; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COLLAGEN; NANDROLONE DECANOATE; TRIACYLGLYCEROL; ANABOLIC AGENT; DRUG DERIVATIVE; NANDROLONE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHLETIC PERFORMANCE; BIOCHEMISTRY; CHOLESTEROL BLOOD LEVEL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; KUPFFER CELL; LIVER FUNCTION; LIVER PARENCHYMA; MALE; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VEIN WALL; WISTAR RAT; ANALYSIS OF VARIANCE; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENZYMOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER; LIVER CELL; LIVER CIRRHOSIS; RANDOMIZATION;

ANABOLIC AGENTS; ANALYSIS OF VARIANCE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTES; INJECTIONS, INTRAMUSCULAR; LIVER; LIVER CIRRHOSIS; MALE; NANDROLONE; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 52149092212     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e3181666f1c     Document Type: Article

References (34)

1. Arthur MJP. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2000;279(2):245-9.
2. Basaria S, Wahlstrom JT, Dobs AS. Anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab. 2001;86(11):5108-17.
3. Boada LD, Zumbado M, Torres S, et al. Evaluation of acute and chronic hepatotoxic effects exerted by anabolic-androgenic steroid stanozolol in adult male rats. Arch Toxicol. 1999;73:465-72.
4. Cato A, Nestl A, Mink S. Rapid actions of steroid receptors in cellular signalling pathways. Sci STKE. 2002;138:RE9.
5. Cunha TS, Tanno AP, Costa Sampaio Moura MJ, Marcondes FK. Influence of high-intensity exercise training and anabolic androgenic steroid treatment on rat tissue glycogen content. Life Sci. 2005;77(9): 1030-43.
6. Damton SJ, Zgainski B, Grenier I, et al. The use of an anabolic steroid (nandrolone decanoate) to improve nutritional status after esophageal resection for carcinoma. Dis Esophagus. 1999;12(4): 283-8.
7. Deicher R, Horl WH. Hormonal adjuvants for the treatment of renal anaemia. Eur J Clin Invest. 2005;35(Suppl. 3):75-84.
8. Fortunato RS, Marassi MP, Chaves EA, Nascimento JH, Rosenthal D, Carvalho DP. Chronic administration of anabolic androgenic steroid alters murine thyroid function. Med Sci Sports Exerc. 2006;38(2):256-61.
9. Frisoli A Jr, Chaves PH, Pinheiro MM, Szejnfeld VL. The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial. J Gerontol A Biol Sci Med Sci. 2005;60(5):648-53.
10. Hartgens F, Van Marken Lichtenbelt WD, Ebbing S, Vollaard N, Rietjens G, Kuipers H. Body composition and anthropometry in bodybuilders: regional changes due to nandrolone decanoate administration. Int J Sports Med. 2001;22(3):235-41.
11. Johansen KL, Painter PL, Sakkas GK, Gordon P, Doyle J, Shubert T. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial. J Am Soc Nephrol. 2006;17(8):2307-14.
12. Kanda N, Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci. 2005;38(1):1-7.
13. Kiraly CL. Androgenic-anabolic steroid effects on serum and skin surface lipids, on red cells, and on liver enzymes. Int J Sports Med. 1988;9(4):249-52.
14. Kolios G, Valatas V, Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol. 2006; 12(46):7413-20.
15. Kossakowska AE, Edwards DR, Lee SS, et al. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol. 1998; 153(3): 1895-902.
16. Kuipers H, Wijnen JA, Hartgens F, Willems SM. Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders. Int J Sports Med. 1991;12(4):413-8.
17. Maravelias C, Dona A, Stefanidou M, Spiliopoulou C. Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett. 2005;158:167-75.
18. Markova MS, Zeskand J, McEntee B, Rothstein J, Jimenez SA, Siracusa L. A role for the androgen receptor in collagen content of the skin. J Invest Dermatol. 2004; 123(6): 1052-6.
19. Marqueti RC, Parizotto NA, Chriguer RS, Perez SE, Selistre-de-Araujo HS. Androgenic-anabolic steroids associated with mechanical loading inhibit matrix metallopeptidase activity and affect the remodeling of the achilles tendon in rats. Am J Sports Med. 2006;34(8):1274-80.
20. Marshall E. The drug of champions. Science. 1988;242(4876):183-4.
21. Mulligan K, Zackin R, Clark RA, et al. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. Arch Intern Med. 2005;165(5):578-85.
22. Muriel P, Escobar Y. Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride. J Appl Toxicol. 2003;23(2):103-8.
23. Nunez M. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. J Hepatol. 2006;44:S132-9.
24. Radovanovic D, Jovanovic D, Mihailovic D, Rankovic G, Stojiljkovic N, Dimitrov V. Hepatoprotective effects of silymarin in androgenic-anabolic steroid-induced liver damage. Med Pregl. 2003;56(Suppl. 1):79-83.
25. Saborido A, Molano F, Megias A. Effect of training and anabolic-androgenic steroids on drug metabolism in rat liver. Med Sci Sports Exerc. 1993;25(7):815-22.
26. Sanchez-Conde M, Berenguer J, Miralles P, et al. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase. Clin Infect Dis. 2006;43(5):640-4.
27. Seidel D. Lipoproteins in liver disease. J Clin Chem Clin Biochem. 1987;25(9):541-51.
28. Socas L, Zumbado M, Perez-Luzardo O, et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med. 2005;39:e27.
29. Tavill AS. The synthesis and degradation of liver-produced proteins. Gut. 1972;13(3):225-41.
30. Thiblin I, Petersson A. Pharmacoepidemiology of anabolic androgenic steroids: a review. Fundam Clin Pharmacol. 2005;19:27-44.
31. Todd T. Anabolic steroids: the gremlins of sport. J Sports Hist. 1987;14(1):87-107.
32. Triantafillopoulos IK, Banes AJ, Bowman KF Jr, Maloney M, Garrett WE Jr, Karas SG. Nandrolone decanoate and load increase remodeling and strength in human supraspinatus bioartificial tendons. Am J Sports Med. 2004;32(4):934-43.
33. Vieira RP, Claudino RC, Duarte ACS, et al. Aerobic exercise decreases chronic allergic lung inflammation and airway remodeling in mice. Am J Respir Crit Care Med. 2007:I76(9):871-77.
34. Wang H, Wei W, Wang NP, et al. Melatonin ameliorates carbon tetrachloride-induced hepatic fibrogenesis in rats via inhibition of oxidative stress. Life Sci. 2005;77(15):1902-15.